Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
schistosomiasis
MeSH D012552 - schistosomiasis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D000079426:
Vector borne diseases
0 Companies
0 Drugs
Success rate
D014201:
Trematode infections
0 Companies
0 Drugs
Success rate
D012552:
Schistosomiasis
2 Companies
1 Drug
$
Success rate
D012553:
Schistosomiasis haematobia
0 Companies
0 Drugs
Success rate
D012554:
Schistosomiasis japonica
0 Companies
0 Drugs
Success rate
D012555:
Schistosomiasis mansoni
1 Company
1 Drug
$
Success rate
D020818:
Neuroschistosomiasis
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Bayer
Praziquantel
Biltricide
1982-12-29
Endo
Praziquantel
Praziquantel
2017-11-27
Clinical Trials
Historical Success Rate
Phase 1
100
%
2/2
Phase 2
33
%
1/3
Phase 3
100
%
2/2
Approved:
1
Overall Success rate:
33%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Bayer
Praziquantel
,
Praziquantel, (r)-
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use